What to expect from PEGS Europe 2023: Day 3
Drug Discovery World
NOVEMBER 13, 2023
Checkpoints and agonists This final session in the track will feature five presentations, which include: Timo Van den Berg, PhD, Senior Director, Immuno-Oncology Research, Byondis, on: ‘ The CD47-SIRPα myeloid immune checkpoint: Considerations for targeting and preclinical characterisation of BYON4228’.
59 
Let's personalize your content